Biology and therapeutic potential of prostacyclin.
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy; D001241:Aspirin / Q000494:pharmacology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D000242:Cyclic AMP / Q000378:metabolism; D015118:Eicosapentaenoic Acid; D011464:Epoprostenol / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000378:metabolism*; D013928:Thromboxane A2 / Q000378:metabolism / Q000627:therapeutic use; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors
D005231:Fatty Acids, Unsaturated; D011453:Prostaglandins; D013928:Thromboxane A2; D015118:Eicosapentaenoic Acid; D011464:Epoprostenol; D000242:Cyclic AMP; D013930:Thromboxane-A Synthase; D001241:Aspirin